Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study

Shengjie Yang,1 Wenjie Zhang,1,2 Qing Chen,1 Qisen Guo1 1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People’s Republic of China; 2Department of Oncology, Weifang Medical University, Weifang, Shandong, People&...

Full description

Bibliographic Details
Main Authors: Yang S, Zhang W, Chen Q, Guo Q
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/clinical-investigation-of-the-efficacy-and-safety-of-anlotinib-with-im-peer-reviewed-article-CMAR